Inactive Instrument

Highlights Prometheus Biosciences, Inc.

Equities

RXDX

US74349U1088

Highlights

Unlock all the news on all businesses: Never miss an investment opportunity again!

Paris-listed Drugmaker Merck & Co. Buys Prometheus Biosciences	23-06-19	MT
Merck & Company Completes Acquisition of Prometheus Biosciences for $10.8 Billion in Cash; to Cut EPS Outlook in August	23-06-16	MT
Merck & Co., Inc. completed the acquisition of Prometheus Biosciences, Inc. from a group of shareholders.	23-06-15	CI
Analysis-Amgen's antitrust woes spur wider pharmaceutical deal fears	23-05-17	RE
US FTC sues to block Amgen's $27.8 bln deal for Horizon Therapeutics	23-05-16	RE
Prometheus Biosciences, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023	23-05-09	CI
Earnings Flash (RXDX) PROMETHEUS BIOSCIENCES Reports Q1 Revenue $1.1M	23-05-09	MT
Drugmakers scout for deals, ramp up research spending	23-04-27	RE
Prometheus Biosciences Surges After Merck's Takeover Announcement	23-04-17	MT
Wall St slips as Fed seen hiking rates in May; State Street sinks	23-04-17	RE
Trending : Merck Buys Prometheus Biosciences for $10.8 Billion	23-04-17	DJ
Merck to take $10.3 billion R&D charge for Prometheus deal this year	23-04-17	RE
Wall St set for muted open as investors focus on earnings, Fed cues	23-04-17	RE
Mixed Economic Data, Bank Earnings Weighed Amid Higher Exchange-Traded Funds, Equity Futures in Pre-Bell Activity	23-04-17	MT
RTW Venture eyes Prometheus takeover to up net asset value	23-04-17	AN
Merck Buying Prometheus Biosciences for $10.8 Billion to Enhance Immunology Portfolio	23-04-17	MT
North American Morning Briefing : Subdued Open Seen as More Earnings Eyed	23-04-17	DJ
Prometheus Biosciences Shares Soar Premarket on Takeover by Merck	23-04-17	DJ
Marketmind: Banks calm the horses	23-04-17	RE
Merck to Acquire Prometheus Biosciences for $200 per Share	23-04-17	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Highlights Prometheus Biosciences, Inc.

Equities

RXDX

US74349U1088

Highlights

Filters